Apricity secures £14.7m Series B funding led by MTIP to expand across Europe

Apricity, a virtual fertility clinic based in London, has secured £14.7m in a Series B funding round led by Swiss healthtech investor MTIP, with participation from consumer specialist fund Iris Ventures. The capital will be deployed to accelerate domestic growth, launch into new European markets including Spain, Germany and Italy, and further develop the company technology stack, which features artificial intelligence algorithms and 3D embryo reconstruction.

Founded in 2018 and initially incubated by Kamet Ventures, the clinic combines digital tools with clinical care to assist patients through fertility treatment. The company has experienced rapid expansion over the past year, doubling its revenue and customer base, while also scaling its corporate employee benefits offering through partnerships with corporate clients and insurers such as AXA and Reward Gateway.

MTIP Managing Partner Christoph Kausch highlighted the firm position as an early pioneer in virtual healthcare models. Meanwhile, incoming board member Marc Dietrich and Iris Ventures founder Montse Suarez pointed to the rising importance of fertility technology and consumer-centric healthcare delivery as key drivers behind the investment.